ID

24686

Description

Study ID: 100478 Clinical Study ID: 100478 Study Title: Study to show non-inferiority of Tritanrix™-HepB/Hib-MenAC (+/- hepatitis B vaccine at birth) versus Tritanrix™-HepB/Hiberix™ without hepatitis B vacc. at birth for antibody response to all vaccine antigens given in healthy infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00290303 Sponsor: GlaxoSmithKline Phase: phase 3 Study Recruitment Status: Completed Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine Trade Name: Tritanrix HepB/Hiberix Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis This form contains the Non-Serious Adverse Events form

Keywords

Versions (1)
  1. 8/13/17 8/13/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 13, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

English

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 forms  
Non-Serious Adverse Event
Description

Non-Serious Adverse Event

Alias
UMLS CUI-1
C1518404
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Description

non-serious adverse event

Data type

boolean

Alias
UMLS CUI [1]
C1518404
AE No.
Description

AE No.

Data type

integer

Alias
UMLS CUI [1]
C0877248
Description:
Description

Description

Data type

text

Alias
UMLS CUI [1]
C0678257
Administration Site
Description

Administration Site

Data type

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0013153
UMLS CUI [1,3]
C0042210
Non-administration site
Description

Non-administration site

Data type

boolean

Alias
UMLS CUI [1,1]
C1515974
UMLS CUI [1,2]
C0042210
Date Started:
Description

Date Started:

Data type

date

Alias
UMLS CUI [1]
C0011008
during immediate postvaccination period (30 minutes)
Description

immediate postvaccination

Data type

boolean

Alias
UMLS CUI [1,1]
C0231291
UMLS CUI [1,2]
C0877248
Date Stopped:
Description

Date Stopped:

Data type

date

Alias
UMLS CUI [1]
C0011008
Maximum Intensity:
Description

Maximum Intensity:

Data type

integer

Alias
UMLS CUI [1]
C0518690
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Description

Relationship to investigational products:

Data type

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
Outcome:
Description

Outcome:

Data type

integer

Alias
UMLS CUI [1]
C1705586
Medically attended visit:
Description

(Refer to protocol for full definition.)

Data type

boolean

Alias
UMLS CUI [1]
C0545082
Medically attended visit. If yes please specify type
Description

Refer to protocol for full definition.

Data type

integer

Alias
UMLS CUI [1]
C0545082
Back to the top of the page

Similar models

GSK non-inferiority of Tritanrix Hepatitis B NSAE NCT00290303

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Non-Serious Adverse Event
C1518404 (UMLS CUI-1)
non-serious adverse event
Item
Has any non-serious adverse events occurred within one month (minimum 30 days) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
boolean
C1518404 (UMLS CUI [1])
AE No.
Item
AE No.
integer
C0877248 (UMLS CUI [1])
Description
Item
Description:
text
C0678257 (UMLS CUI [1])
Administration Site
Item
Administration Site
boolean
C1515974 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Non-administration site
Item
Non-administration site
boolean
C1515974 (UMLS CUI [1,1])
C0042210 (UMLS CUI [1,2])
Date Started:
Item
Date Started:
date
C0011008 (UMLS CUI [1])
immediate postvaccination
Item
during immediate postvaccination period (30 minutes)
boolean
C0231291 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Date Stopped:
Item
Date Stopped:
date
C0011008 (UMLS CUI [1])
Item
Maximum Intensity:
integer
C0518690 (UMLS CUI [1])
Maximum Intensity:
Code List
Maximum Intensity:
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Relationship to investigational products:
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0877248 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
Item
Outcome:
integer
C1705586 (UMLS CUI [1])
Outcome:
Code List
Outcome:
CL Item
Recovered / resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae / resolved with sequelae (4)
Medically attended visit:
Item
Medically attended visit:
boolean
C0545082 (UMLS CUI [1])
Item
Medically attended visit. If yes please specify type
integer
C0545082 (UMLS CUI [1])
Medically attended visit:
Code List
Medically attended visit. If yes please specify type
CL Item
Hospitalisation (1)
CL Item
Emergency Room (2)
CL Item
Medical Personnel (3)
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial